Response from a Subject Editor
Dear Reader, I would like to respond to the above letter to the editor with regards to the aforementioned article by Pujani et al. 1 Small-cell neuroendocrine carcinoma (NEC) of the cervix is uncommon and accounts for less than 2% of all cervical cancers. 2 Although the diagnostic work-up for squamous cell carcinomas (SCCs) or adenocarcinomas of the cervix is very well described, the management plan for a cervical NEC is essentially extrapolated from that of cervical SSC and/or NEC of the lung. Up to 85% of cervical NEC cases may be caused by the human papilloma virus (HPV), especially strains 16 and 18, with very few case reports implicating HIV in the aetiopathogenesis of this tumour. 3, 4 Overall, NEC is an aggressive cancer in which over 50% of patients present at an advanced stage; additionally, patients have a poorer prognosis and a higher chance of recurrence compared to those with SCCs or adenocarcinomas of the cervix. 5 Various factors-including the age of the patient, clinical stage and extent of the disease (i.e. tumour size, parametrial involvement, depth of stromal invasion and lymph node metastasis) and type of treatment (either a radical hysterectomy in the early stages or chemotherapy for advanced disease)-predict survival after treatment. 6 In their recent study of the molecular characteristics of cervical NEC, Xing et In summary, although SNEC of the cervix is an uncommon cancer, recent research suggests that it follows an aggressive course, regardless of the patient's immune status. 6, 7 Surveillance for HIV is therefore not routinely recommended and should be considered only in cases wherein the patient's clinical features or results of routine serological investigations raise suspicion of the disease.
